arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Xtant Medical Holdings, Inc.

XTNT
$0.37 ▲ +0.03 (+10.12%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
67 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
63
Health
Fair
Neutral
auto_awesome

Analytical Summary

Xtant Medical Holdings, Inc. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $51.9M
Dividend Yield
Revenue Growth -35.0%
Op. Margin -39.8%
ROIC -19.5%
FCF / Share $-0.05
Trailing P/E
Price / Book 1.3x
FCF Yield
Debt / Equity 0.18
info Valuation on last close. End-of-day price, Sep 22, 2026.

67-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$23.03M
↓ -35.0%
Net Income Profit after all expenses
$-3.09M
— 0.0%
Operating Margin Operating profit as % of sales
-39.8%
↓ -184.4% 44th
FCF / Share Free cash flow per share
$-0.05
↓ -226.9%
Long-Term Debt Long-term obligations
$7.29M
↓ -10.0%

Health Breakdown

Profitability
47
Returns
67
Financial Health
65
Cash Quality
86

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 17 years · 67 quarters